COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
28/08/2017
FIT Biotech Oy Company release August 28, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - June 30, 2017
28/08/2017
Message from the CEO IBT are currently in the completion stage of the phase II clinical trial (NCT02472769) and are concurrently working with preparations for a subsequent phase III clinical trial. The phase II clinical [...]
Sanofi completes the acquisition of Protein Sciences
28/08/2017
Sanofi completes the acquisition of Protein Sciences - An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio - Paris, France - August 28, 2017 - Sanofi announced today that it has [...]
Sanofi finalise l'acquisition de Protein Sciences
28/08/2017
Sanofi finalise l'acquisition de Protein Sciences - Un vaccin antigrippal quadrivalent innovant viendra compléter la gamme de vaccins de Sanofi Pasteur - Paris, France - Le 28 août 2017 - Sanofi annonce aujourd'hui [...]
Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
28/08/2017
1. Settlement of vested restricted stock units ("RSUs") Robert Burns, member of the board of directors of Targovax ASA (the "Primary Insider"), has on 25 August 2017 subscribed for 40,984 shares in Targovax ASA at a [...]
Santhera to Publish First Half-Year Report and Corporate Update on September 5, 2017
28/08/2017
Liestal, Switzerland, August 28, 2017 - Santhera Pharmaceuticals (SIX: SANN) will publish its 2017 first half-year report and corporate update on Tuesday, September 5, 2017 at 07:00 CET. An investor conference call with [...]
Novartis Phase III CANTOS study demonstrates that targeting inflammation with ACZ885 reduces cardiovascular risk
27/08/2017
Study showed a significant 15% reduction of major adverse cardiovascular events (MACE) in people with a prior heart attack and inflammatory atherosclerosis who were treated with 150mg of ACZ885, in addition to standard [...]
Novartis announces analysis published in The Lancet showing ACZ885 reduced lung cancer mortality by 77% in the CANTOS study with further studies planned
27/08/2017
Review of blinded, pre-planned oncology safety analyses revealed a 77% reduction in lung cancer mortality and 67% reduction in lung cancer cases in patients treated with 300mg of ACZ885 CANTOS is the first Phase III [...]
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2018
25/08/2017
DUBLIN - August 25, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 second quarter cash dividend of $0.46 per ordinary share, representing a 7 percent increase over the [...]
Centre for Aging + Brain Health Innovation announces up to $3 million in funding available to support industry innovations in the field of aging and brain health
25/08/2017
TORONTO, Aug. 25, 2017 (GLOBE NEWSWIRE) -- The Centre for Aging + Brain Health Innovation (CABHI) announced today the second round of funding available through its Industry Innovation Partnership Program (I 2 P 2 ). [...]
Victoza® approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of major adverse cardiovascular events
25/08/2017
Bagsværd, Denmark, 25 August 2017 - The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza ® (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with [...]
Summit Therapeutics plc : Notice of Results
25/08/2017
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 31 JULY 2017 ON 31 AUGUST 2017 Oxford, UK, · August 2017 - Summit [...]
Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen
25/08/2017
Proceeds from amended agreement, combined with finances raised from recent public stock offering and current financial resources, significantly extend Minerva cash runway Combined proceeds are expected to support [...]
Zealand grants new warrants under employee warrant program
25/08/2017
Company announcement - No. 41/2017 Zealand grants new warrants under employee warrant program Copenhagen, August 25, 2017 - Zealand announces the grant of warrants to the Company's President and CEO Britt Meelby Jensen [...]
Exercise of employee share options and restricted stock units in Targovax ASA
25/08/2017
Reference is made to the stock exchange notice of 18 August 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units [...]
Shire plc : Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors
25/08/2017
Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors Collaboration leverages digital technology to provide free and secure care monitoring tool Lexington [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
25/08/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
25/08/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Aino Health AB (publ) publishes Interim Report 1 April - 30 June 2017
25/08/2017
Aino Health AB (publ) has published its Interim Report for the second quarter, 1 April - 30 June 2017 today. It is available on the Aino Health website, see also attached pdf-document. Three important events - Turnover [...]

Pages